Quantcast Merck And Co News - Congoo
 
 
Log In
  COMPANY NEWS >> MERCK AND CO    Get our Merck and Co daily Briefing     
3M
Alcoa
Altria
American Express
Boeing
Caterpillar Inc
Citigroup
Coca-cola
DuPont
Eastman Kodak
Exxon Mobil
General Electric Company
Hewlett-Packard
Home Depot
Honeywell International
IBM
Intel
Johnson & Johnson
JP Morgan
McDonalds
Merck and Co
Microsoft
Procter and Gamble
Wal-Mart Stores
Walt Disney
 
 



Merck Serono: CHMP Opinion for Erbitux in Advanced Non-Small Cell Lung Cancer   - 4 Hours ago
The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has adopted a negative opinion for the use of Erbitux
  
    



Ligand Earns $2 Million Merck Milestone   - 4 Hours ago
has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck, through its research collaboration, which is due to expire at the end of December. We have had a long and productive
  
    




UNPA Commends FDA Actions Against Steroids   - 4 Hours ago
00--0 1::00 The United Natural Products Association (UNPA) commended FDA action to recall five products illegally marketed as sports enhancing dietary supplements. Loren Israelsen, executive director,
  
    



Vitamin Beats Statin: Is Merck's Zetia in Trouble?   - 6 Hours ago
The Burrill Report submits: A small study is causing a big splash in the multi-billion dollar world of cholesterol treatments. The test, pitting a prescription form of the B vitamin niacin against the
  
    



Merck, Shopping in the UK?   - 7 Hours ago
So, according to this report, Merck is scouting out locations for a UK facility. No word if it's supposed to have a research component, but. . .as a correspondent points out, if only there were a large
  
    



US stocks join global retreat   - 6 Hours ago
US stocks fell, joining a global retreat, as earnings at Dell Inc. and D.R. Horton Inc.
  
    


Reach your target audience with AdBlade! Sponsored
- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents.  Try AdBlade and begin reaching your targ.  Learn More



NEW MERCK BEGINS OPERATIONS WORLDWIDE   - 15 Hours ago
Merck & Co., Inc. (NYSE: MRK) today outlined its global strategy following the completion yesterday of Merck's merger with Schering-Plough Corporation.  The new Merck, operating as MSD outside the United
  
    



Inovio, Merck gain; Novavax falls   - 12 Hours ago
Drug stocks were mostly higher Friday while shares of Inovio Biomedical soared on positive clinical data for its new DNA-based flu vaccine. The NYSE Arca Pharmaceutical Index was up 0.6% at 303.54 while
all 1 news articles >>
  
    



Ligand wins $2 million milestone payments from NV Organon - Zibb....   - 19 Hours ago
Companies: Ligand Pharmaceuticals, Inc. (LGND), Merck & Co., Inc. (MRK) Ligand Pharmaceuticals has received $2 million in milestone payments from NV Organon, a subsidiary of Merck & Co, stemming from
all 1 news articles >>
  
    


American Express takes you places Sponsored
The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase.  Learn More



5-Star Stocks Poised to Pop: NRG Energy   - 19 Hours ago
Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, power plant operator NRG Energy (NYSE: NRG) has earned a coveted
all 3 news articles >>
  
    



Merck Receives CHMP Positive Opinion for Fertility Treatment   - 11 Hours ago
Merck & Co. Inc. announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency has recommended approval of ELONVA, or corifollitropin alfa injection, as a treatment
all 6 news articles >>
  
    



Encouraging results for Merck heart drug   - 22 Hours ago
Merck's investigational heart drug anacetrapib has shown encouraging results in a phase IIb study. Patients receiving higher doses experienced benefits on both 'good' (HDL-C) and 'bad' (LDL-C) cholesterol
  
    


Ernst & Young - The right transaction Sponsored
No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle.  Learn More



Merck Presents Phase IIb Study Results at AHA Annual Scientific S...   - 6 Hours ago
Company: Merck & Co., Inc. (MRK) In a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co-administered with atorvastatin,
all 2 news articles >>
  
    



New data for odanacatib showed positive results in treating osteoporosis   - 11/20/2009
New data from a Phase IIB clinical study of odanacatib, Merckâ??s oral, once-weekly investigational treatment for osteoporosis, showed that when stopping treatment after two years, the increases in lumbar
  
    



US midday: Dow remains lower   - 11/19/2009
Wall Street remains sharply lower as the US market loses part of last week's gains. The Dow is 123 points lower at 10,303. Nasdaq is down 39 at 2,154 while the S&P 500 is 17 lower at 1,092. Merck and
  
    



Market Snapshot: Wall Street faces worst outing of the month   - 11/19/2009
Investors, prompted by economic worries, scale back risk in portfolios Explore related topics Internet Software Dow Jones Industrial Average Intel Corporation Merck & Co Inc New Story Quotes Comments
  
    



Merck scouts U.K. for new site, paper says   - 11/19/2009
Merck may be planning to shutter some facilities as it absorbs Schering-Plough. But the U.S.-based drugmaker is also scouting sites for a "major new facility," a U.K. business publication reports. Merck
  
    



Ligand Earns $2 Million Merck Milestone   - 4 Hours ago
has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck, through its research collaboration, which is due to expire at the end of December. We have had a long and productive
all 4 news articles >>
  
    



Dow Tries to Claw Higher as Merck Gains   - 14 Hours ago
Stocks declined Friday as technology shares took yet another hit â?? this time it was weak earnings from PC maker Dell. But as the closing bell neared, the Dow Jones Industrial Average briefly pushed
all 1 news articles >>
  
    



Pops & Drops: Merck, Monsanto...   - 11 Hours ago
Lee BrodieProducerFollowing are the weekâ??s biggest winners and losers. Find out why shares of Merck and Monsanto popped while Sony and the Semiconductor ETF dropped.POPS (stocks that jumped higher)Merck
all 1 news articles >>
  
    



Higher Dose of Merck's COZAAR (Losartan Potassium Tablets) Significantly Reduced   - 11/19/2009
In an investigational study, Merck's medicine COZAAR (losartan potassium tablets) 150 mg, administered once daily, significantly reduced the risk of all-cause death or hospitalization due to heart failure
all 1 news articles >>
  
    



Merck F1Q09 Earnings Call Transcript   - 11/19/2009
8:30 am ET Executives Eva Boratto - Vice President of Investor Relations Richard T. Clark - Chairman, President and Chief Executive Officer Kenneth C. Frazier - Executive Vice President and President
all 1 news articles >>
  
    



Dispensary of Hope Partners with Leading Pharma Companies to Expand Prescription   - 11/18/2009
Three National Pharma Companies to Contribute to Dispensary's Continued Access Program NASHVILLE, Tenn.--(Business Wire)-- Through a pioneering program - the Continued Access Program - the Dispensary
  
    



Your Heart or Your Stomach?   - 11/18/2009
Recs 0 //Create your sharelet with desired properties and set button element to false object //Tie customized button to This button functionality. element Disney Buys Marvel! David Gardner called it.
  
    



Dynavax Completes Enrollment of First Cohort of Patients in Phase 1b Clinical Trial   - 8 Hours ago
Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that enrollment has been completed for the first of three cohorts of patients receiving DV-601 hepatitis B therapy in a Phase 1b clinical
all 4 news articles >>
  
    
*Votes may take up to 30 minutes to influence article rank order
Featured Members
Steve Macey Steve Macey
Inside Sales Coordinator
Caterpillar Inc
Magdalena Magdalena
Six Sigma Black Belt
General Electric Company
Dean Oblate Dean Oblate
3M
faster fene faster fene
asd
Exxon Mobil

  Add your Profile
  View more profiles

   




 
 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.